Key points are not available for this paper at this time.
Management of serum cholesterol level is a central objective in preventing cardiovascular events. Current guidelines recommend calculation of cardiovascular risk, with treatment decisions based on these data and clinician–patient discussion of risk. Statins remain the first line of pharmacotherapy.
Michos et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: